Aureon Laboratories

About:

Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options.

Top Investors: Pfizer, Atlas Venture, Pfizer Venture Investments, New Leaf Venture Partners, Sprout Group

Description:

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Total Funding Amount:

$73.3M

Headquarters Location:

New York, New York, United States

Founded Date:

2001-01-01

Founders:

Jon Edelson

Number of Employees:

Last Funding Date:

2011-09-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai